http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106236719-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106236719-B
titleOfInvention Pharmaceutical composition containing mecobalamin and preparation method thereof
abstract The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to a pharmaceutical composition containing mecobalamin and a preparation method thereof. The pharmaceutical composition containing mecobalamin comprises the following components in percentage by mass: 0.01-1% of mecobalamin, 1-10% of stabilizing agent, 40-95% of diluent, 0-20% of disintegrating agent and 0.1-10% of lubricant; the preparation method comprises the steps of premixing mecobalamin and part of diluent, mixing the premix with the stabilizer, the diluent and the disintegrant to obtain mixed powder, mixing the mixed powder with the lubricant for a certain time to obtain mixed raw and auxiliary material powder, and directly tabletting and coating the mixed raw and auxiliary material powder. The dry granulation is adopted, the process steps are few, the influence of moisture and heat on the main drug is avoided, the quality of the mecobalamin tablets is further improved, the cost is reduced, and the industrial production is facilitated.
priorityDate 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008280268-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16056828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139033638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448554029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449920682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551089

Total number of triples: 44.